MPT · NYSE · REIT - Healthcare Facilities

Medical Properties Trust (MPT)

Acquires hospital properties and leases them to operators under long-term net leases.

$3.57
vs last close−0.08 (−2.09%)
Loading prices…

Medical Properties Trust, Inc.MPT
Real Estate

Owns hospital real estate and leases it to healthcare operators, often pairing property transactions with operator financing. The portfolio spans the United States, Europe, and Colombia, while rent collection depends on tenant performance and the ongoing transition of former Steward facilities.

Acquires and develops hospital real estate, then leases facilities to healthcare operators under long-term net leases. The model can release capital tied up in hospital property, while selected transactions also include mortgage loans or operator investments.

General acute-care and behavioral-health facilities anchor a portfolio spread across the United States, Europe, and Colombia. Growth has relied on assembling operator-linked portfolios and financing cross-border acquisitions; the current phase emphasizes selected sales, refinancing, and limited new purchases.

Rent collection ultimately depends on the financial health of a concentrated group of hospital operators. Former Steward facilities are under replacement tenants with rents still ramping, Prospect exposure has been reduced through restructuring, and debt refinancing remains active. These tenant transitions and capital obligations shape cash generation from the portfolio.

Company facts

CEOEdward K. Aldag Jr.
ListedJul 7, 2005
ExchangeNYSE
HeadquartersBirmingham, AL
CountryUnited States
Employees121
CIK0001287865
ISINUS58463J3041

Market cap$2.18B
EPS (ttm)−$0.0525
P/E (ttm)−69.52
ROE-0.7%
P/B0.4852
P/S2.14
Dividend yieldDiv yield9.86%
Beta0.53vs XLRE 0.84

Price target$3.80+4.1%Average of 28 analysts
ConsensusHold13 of 28 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Sep 1, 2026Wells FargoReiterate
Rating: Target: $5
Rating: UnderweightTarget: $3.80
Feb 3, 2026Maxim GroupTarget
Target:
Target: $8
Nov 25, 2025Wells FargoReiterate
Rating: Target: $7.50
Rating: UnderweightTarget: $5
Mar 12, 2025Exane BNP ParibasUpgrade
Rating: Neutral
Rating: Outperform

Next report
Oct 29, 26
in 37 days
EPS estimate
−$0.01
Revenue estimate
$254.6M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Jul '25Oct '25Feb '26Apr '26Aug '26Oct '26
Reported−$0.69−$0.20−$0.16−$0.13$0.03$0.05−$0.01Pending
Estimate$0.04$0.15$0.00$0.16$0.01$0.03$0.01−$0.01
Surprise−1,825.0%−233.3%−181.3%+130.4%+97.1%−241.4%

RevenueReportedEstimate

Feb '25May '25Jul '25Oct '25Feb '26Apr '26Aug '26Oct '26
Reported$231.8M$223.8M$240.4M$237.5M$270.3M$252.1M$259.3MPending
Estimate$229.7M$230.0M$224.8M$234.0M$240.4M$241.6M$247.3M$254.6M
Surprise+0.9%−2.7%+6.9%+1.5%+12.5%+4.3%+4.9%
Estimate−$0.01
ReportedDue Oct 29, 2026
Estimate$254.6M
ReportedDue Oct 29, 2026
View details

Debt to equity215.70%
Current ratio30.70%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$225.8M$235.3M$223.8M$240.4M$237.5M$270.3M$252.1M$259.3M
Net income−$801.2M−$412.8M−$118.3M−$98.4M−$77.7M$17.3M$32.8M−$2.6M
Net margin0.0%0.0%0.0%0.0%0.0%6.4%13.0%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income−$20.7M$197.0M$110.3M$136.6M$123.8M$169.1M$140.2M$143.9M
YoY growthTurned lossTurned profit−30.0%+12.6%Turned profit−14.2%+27.1%+5.3%

Balance sheet, Jun 30, 2026Cash & short-term investments $396.6M · Total debt $9.70B · Total assets $14.75B · Shareholders' equity $4.50B

Revenue
$259.3M
Operating income
$143.9M
Net income
−$2.6M
View details

Dividend yield
9.86%
Next ex-date
Dec 10, 26
estimated · in 79 days
Annual dividend
$0.36
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Dividend$0.08$0.08$0.08$0.08$0.09$0.09$0.09$0.09
Annual yield11.39%6.64%7.24%6.94%6.43%6.79%7.73%9.81%
Ex-dateDec 12Mar 10Jun 18Sep 11Dec 11Mar 12Jun 18Sep 10
Payment dateJan 9Apr 10Jul 17Oct 9Jan 8Apr 9Jul 16Oct 8
View details

Insiders9.21%55.08M shares
14 holders · as of Aug 20, 2026
Strategic holders11.54%69.02M shares
1 holder · as of Oct 17, 2025
Other79.25%473.99M shares
remainder

598.10M company shares as of Sep 11, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Strategic
11.54%69.02Mfiled Oct 17, 2025
Vanguard Portfolio ManagementInstitution
7.21%43.15Mfiled Apr 29, 2026
He ZhengxuInsider
6.97%41.66Mfiled Jan 6, 2026
Edward K. JR AldagInsiderdirector, officer: Chairman, President & CEO
1.12%6.69Mfiled Jul 8, 2026
R. Steven HamnerInsiderdirector, officer: Executive Vice President & CFO
0.63%3.79Mfiled Jul 8, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 20, 2026James Kevin Hannaofficer: Senior VP, Controller & CAO+2,300$4.15
Dec 15, 2025Rosa Handley Hooperofficer: SVP of Operations−2,000$5.00
Nov 19, 2025Michael G. Stewartdirector−59,000$5.02
View details

Compare

CompanyPriceChange
Medical Properties Trust$3.57−2.09%$2.18B154.22.1+7.9%
Universal Health Realty Income Trust$39.05+0.05%$541.6M27.93.6+0.5%
Chiron Real Estate$36.40+0.50%$479.4M9.33.1−2.2%
Healthcare Realty$18.24−0.19%$6.41B317.05.6−1.8%
Ventas$86.95−0.09%$42.31B161.2120.36.6+21.7%
Healthpeak Properties$20.64−0.41%$14.28B59.2104.24.8+10.5%
Median43.5120.34.8+0.5%